Search
Enovis Corp
ENOVAdd to Watchlist
24.290USD
-1.820-6.97%
Close 05/15, 16:00（ET）Quotes delayed by 15 min
1.40BMarket Cap
LossP/E TTM
More Details of Enovis Corp Company
Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).
Enovis Corp Info
Ticker SymbolENOV
Company nameEnovis Corp
IPO dateMay 08, 2008
CEOMcdonald (Damien)
Number of employees7367
Security typeOrdinary Share
Fiscal year-endMay 08
Address2711 Centerville Road
CityWILMINGTON
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryUnited States of America
Postal code19808
Phone13022529160
Websitehttps://www.enovis.com/
Ticker SymbolENOV
IPO dateMay 08, 2008
CEOMcdonald (Damien)
Company Executives of Enovis Corp
Name
Name/Position
Position
Shareholding
Change
Mr. Daniel Alexis Pryor
Mr. Daniel Alexis Pryor
Executive Vice President - Strategy and Business Development
Executive Vice President - Strategy and Business Development
127.55K
+10.74%
Ms. Sharon L. Wienbar
Ms. Sharon L. Wienbar
Independent Chairman of the Board
Independent Chairman of the Board
32.60K
+13.31%
Mr. Rajiv Vinnakota
Mr. Rajiv Vinnakota
Independent Director
Independent Director
18.11K
-12.48%
Mr. Terry D. Ross
Mr. Terry D. Ross
Group President - Prevention and Recovery
Group President - Prevention and Recovery
18.10K
-95.45%
Mr. Liam J. Kelly
Mr. Liam J. Kelly
Independent Director
Independent Director
13.01K
-17.38%
Dr. Christine Ortiz, Ph.D.
Dr. Christine Ortiz, Ph.D.
Independent Director
Independent Director
9.03K
-16.51%
Ms. Barbara W. Bodem
Ms. Barbara W. Bodem
Independent Director
Independent Director
8.26K
-27.37%
Mr. Brady R. Shirley
Mr. Brady R. Shirley
Director
Director
--
--
Mr. Bradley J. (Brad) Tandy, J.D.
Mr. Bradley J. (Brad) Tandy, J.D.
Senior Vice President, Chief Legal Officer
Senior Vice President, Chief Legal Officer
--
--
Ms. Patricia A. Lang
Ms. Patricia A. Lang
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Daniel Alexis Pryor
Mr. Daniel Alexis Pryor
Executive Vice President - Strategy and Business Development
Executive Vice President - Strategy and Business Development
127.55K
+10.74%
Ms. Sharon L. Wienbar
Ms. Sharon L. Wienbar
Independent Chairman of the Board
Independent Chairman of the Board
32.60K
+13.31%
Mr. Rajiv Vinnakota
Mr. Rajiv Vinnakota
Independent Director
Independent Director
18.11K
-12.48%
Mr. Terry D. Ross
Mr. Terry D. Ross
Group President - Prevention and Recovery
Group President - Prevention and Recovery
18.10K
-95.45%
Mr. Liam J. Kelly
Mr. Liam J. Kelly
Independent Director
Independent Director
13.01K
-17.38%
Dr. Christine Ortiz, Ph.D.
Dr. Christine Ortiz, Ph.D.
Independent Director
Independent Director
9.03K
-16.51%
Revenue Breakdown
Currency: USDUpdated: Mon, Apr 6
Currency: USDUpdated: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
By BusinessUSD
Name
Revenue
Proportion
Medical Technology-Prevention & Rehabilitation
1.14B
50.58%
Medical Technology-Reconstructive
1.11B
49.42%
By RegionUSD
Name
Revenue
Proportion
United States
1.30B
57.62%
Other Foreign locations
952.72M
42.38%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Medical Technology-Prevention & Rehabilitation
1.14B
50.58%
Medical Technology-Reconstructive
1.11B
49.42%
Shareholding Stats
Updated: Thu, May 14
Updated: Thu, May 14
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
14.02%
American Century Investment Management, Inc.
9.14%
Vanguard Portfolio Management, LLC
6.62%
Vanguard Capital Management, LLC
4.43%
Dimensional Fund Advisors, L.P.
4.42%
Other
61.37%
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
14.02%
American Century Investment Management, Inc.
9.14%
Vanguard Portfolio Management, LLC
6.62%
Vanguard Capital Management, LLC
4.43%
Dimensional Fund Advisors, L.P.
4.42%
Other
61.37%
Shareholder Types
Shareholders
Proportion
Investment Advisor
66.66%
Investment Advisor/Hedge Fund
28.44%
Hedge Fund
17.41%
Research Firm
5.91%
Individual Investor
1.53%
Bank and Trust
1.19%
Pension Fund
1.14%
Venture Capital
0.04%
Insurance Company
0.03%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
652
68.97M
119.81%
-6.76M
2025Q4
617
68.12M
125.63%
--
2025Q3
641
68.12M
128.26%
-1.19M
2025Q2
651
69.44M
130.24%
+2.07M
2025Q1
629
67.38M
125.09%
-4.06M
2024Q4
625
63.48M
125.04%
+1.28M
2024Q3
599
62.09M
124.13%
-57.94K
2024Q2
602
61.71M
121.92%
+2.05M
2024Q1
635
59.58M
125.47%
-9.23M
2023Q4
647
58.62M
120.02%
+2.97M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
BlackRock Institutional Trust Company, N.A.
8.07M
14.1%
+110.96K
+1.39%
Dec 31, 2025
American Century Investment Management, Inc.
5.26M
9.19%
+528.25K
+11.17%
Dec 31, 2025
Dimensional Fund Advisors, L.P.
2.78M
4.86%
-189.61K
-6.38%
Dec 31, 2025
Rubric Capital Management LP
2.45M
4.29%
-296.74K
-10.79%
Dec 31, 2025
Davenport Asset Management
2.44M
4.26%
-367.69K
-13.10%
Dec 31, 2025
State Street Investment Management (US)
2.37M
4.14%
+20.61K
+0.88%
Dec 31, 2025
Dorsey Asset Management LLC
2.28M
3.98%
-120.12K
-5.01%
Dec 31, 2025
Fidelity Management & Research Company LLC
1.93M
3.37%
+665.45K
+52.61%
Dec 31, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
State Street SPDR S&P Health Care Equipment ETF
1.83%
Invesco S&P SmallCap Health Care ETF
1.09%
Invesco S&P SmallCap 600 Pure Value ETF
0.45%
State Street SPDR S&P 600 Small Cap Value ETF
0.25%
iShares S&P Small-Cap 600 Value ETF
0.24%
iShares U.S. Medical Devices ETF
0.21%
Humankind US Stock ETF
0.2%
State Street SPDR S&P SmallCap 600 ESG ETF
0.18%
Avantis US Small Cap Equity ETF
0.18%
Invesco S&P SmallCap 600 Revenue ETF
0.16%
View more
State Street SPDR S&P Health Care Equipment ETF
Proportion1.83%
Invesco S&P SmallCap Health Care ETF
Proportion1.09%
Invesco S&P SmallCap 600 Pure Value ETF
Proportion0.45%
State Street SPDR S&P 600 Small Cap Value ETF
Proportion0.25%
iShares S&P Small-Cap 600 Value ETF
Proportion0.24%
iShares U.S. Medical Devices ETF
Proportion0.21%
Humankind US Stock ETF
Proportion0.2%
State Street SPDR S&P SmallCap 600 ESG ETF
Proportion0.18%
Avantis US Small Cap Equity ETF
Proportion0.18%
Invesco S&P SmallCap 600 Revenue ETF
Proportion0.16%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Splits
Date
Ex-dividend Date
Type
Ratio
Mar 18, 2022
Merger
3→1
Mar 18, 2022
Merger
3→1
Mar 18, 2022
Merger
3→1
Mar 18, 2022
Merger
3→1
Date
Ex-dividend Date
Type
Ratio
Mar 18, 2022
Merger
3→1
Mar 18, 2022
Merger
3→1
Mar 18, 2022
Merger
3→1
Mar 18, 2022
Merger
3→1
